HAI-Floxuridine, or SIRT, Combined With Gemox For Patients With Intra-Hepatic Cholangiocarcinoma Not Amenable to Resection (TOMCAT)

NCT06313203 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Intrahepatic Cholangiocarcinoma
Chemotherapy Effect

Interventions

DRUG: Floxuridine
PROCEDURE: Selective Internal Radiation Therapy (SIRT)

Sponsor

Oslo University Hospital